Rosen law firm urges novo nordisk a/s (nyse: nvo) stockholders with losses in excess of $100k to contact the firm for information about their rights

New york--(business wire)--rosen law firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of securities of novo nordisk a/s (nyse: nvo) between november 2, 2022 and december 19, 2024. novo describes itself as a “healthcare company, focused on the research, development, manufacturing, and distribution of pharmaceutical productions globally.” for more information, submit a form, email attorney phillip kim, or give us a call at 866-767-.
NVO Ratings Summary
NVO Quant Ranking